Nippon Boehringer Ingelheim Co., Ltd.

The Boehringer Ingelheim group has been transforming lives in healthcare since 1885. Our 53,000 employees in 130 markets create value through innovation by infusing long-term, sustainable thinking into our Human Pharma and Animal Health units.

We acknowledge the deep and complex ways the lives of humans and animals are interconnected and work on breakthrough therapies and co-create solutions that help millions of people worldwide live longer, healthier lives.

Boehringer Ingelheim is a research-driven group of companies dedicated to the discovery, development, manufacture and marketing of innovative health care products.

***

■ Branch offices: Miyagi (Sendai), Saitama, Aichi (Nagoya), Osaka, Hiroshima, Fukuoka

■ R&D: Hyogo (Kobe)

● Headquarters in Germany: Boehringer Ingelheim GmbH (Ingelheim am Rhein, Rhineland-Palatinate)

(March 2024)